<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tusi BK</submitter><funding>Cancer Research UK</funding><funding>NIAID NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>National Institutes of Health</funding><pagination>1505-15</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4396605</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>29(4)</volume><pubmed_abstract>SETD1A is a member of trithorax-related histone methyltransferases that methylate lysine 4 at histone H3 (H3K4). We showed previously that Setd1a is required for mesoderm specification and hematopoietic lineage differentiation in vitro. However, it remains unknown whether or not Setd1a controls specific hematopoietic lineage commitment and differentiation during animal development. Here, we reported that homozygous Setd1a knockout (KO) mice are embryonic lethal. Loss of the Setd1a gene in the hematopoietic compartment resulted in a blockage of the progenitor B-cell-to-precursor B-cell development in bone marrow (BM) and B-cell maturation in spleen. The Setd1a-cKO (conditional knockout) mice exhibited an enlarged spleen with disrupted spleen architecture and leukocytopenia. Mechanistically,</pubmed_abstract><journal>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</journal><pubmed_title>Setd1a regulates progenitor B-cell-to-precursor B-cell development through histone H3 lysine 4 trimethylation and Ig heavy-chain rearrangement.</pubmed_title><pmcid>PMC4396605</pmcid><funding_grant_id>R01 HL090589</funding_grant_id><funding_grant_id>R01HL090589</funding_grant_id><funding_grant_id>16753</funding_grant_id><funding_grant_id>R01 AI058150</funding_grant_id><funding_grant_id>R01HL095674</funding_grant_id><funding_grant_id>R01 HL091929</funding_grant_id><funding_grant_id>R01HL091929</funding_grant_id><funding_grant_id>R01 HL095674</funding_grant_id><pubmed_authors>Qiu Y</pubmed_authors><pubmed_authors>Deng C</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Huang S</pubmed_authors><pubmed_authors>Tusi BK</pubmed_authors><pubmed_authors>Zeumer L</pubmed_authors><pubmed_authors>Salz T</pubmed_authors><pubmed_authors>So CW</pubmed_authors><pubmed_authors>Morel LM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Setd1a regulates progenitor B-cell-to-precursor B-cell development through histone H3 lysine 4 trimethylation and Ig heavy-chain rearrangement.</name><description>SETD1A is a member of trithorax-related histone methyltransferases that methylate lysine 4 at histone H3 (H3K4). We showed previously that Setd1a is required for mesoderm specification and hematopoietic lineage differentiation in vitro. However, it remains unknown whether or not Setd1a controls specific hematopoietic lineage commitment and differentiation during animal development. Here, we reported that homozygous Setd1a knockout (KO) mice are embryonic lethal. Loss of the Setd1a gene in the hematopoietic compartment resulted in a blockage of the progenitor B-cell-to-precursor B-cell development in bone marrow (BM) and B-cell maturation in spleen. The Setd1a-cKO (conditional knockout) mice exhibited an enlarged spleen with disrupted spleen architecture and leukocytopenia. Mechanistically,</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Apr</publication><modification>2025-04-18T17:30:12.652Z</modification><creation>2019-03-26T23:55:41Z</creation></dates><accession>S-EPMC4396605</accession><cross_references><pubmed>25550471</pubmed><doi>10.1096/fj.14-263061</doi></cross_references></HashMap>